Abstract
ObjectiveA post-hoc analysis of the INCREASE trial and its open-label extension (OLE) was performed to evaluate whether inhaled treprostinil has a long-term survival benefit in patients with pulmonary hypertension associated...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have